Glimepiride, Empagliflozin, and Sitagliptin With Metformin for Type 2 Diabetes

Clinical trial NCT06759922 · COMPLETED

Trial details

NCT number: NCT06759922
Sponsor: Bahria University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2025-01-01
Primary completion: 2025-03-30
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.